Thanks V - that is what I thought I am familiar with the lengthiness of review processes due to my legal background so I was skeptical about the heresy on the thread as to the exact date of FDA correspondence.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
